P/E ratio for Guardant Health (GH)
P/E ratio as of September 2023 (TTM): -5.25
According to Guardant Health 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -5.25458. At the end of 2021 the company had a P/E ratio of -25.0.
P/E ratio history for Guardant Health from 2018 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | -25.0 | -49.94% |
| 2020 | -50.0 | -46.3% |
| 2019 | -93.0 | 159.21% |
| 2018 | -35.9 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Neogen NEOG | -251 | 4,668.45% | 🇺🇸 USA |
 Natera NTRA | -9.33 | 77.56% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.